Dexmedetomidine as a premedication to reduce emergence agitation and pain in adults after closed reduction of nasal bone fracture

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000585

Enrollment

116

Registered

2012-11-19

Start date

2012-10-17

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Using a computer generatined randomization table,Patients are randomely allocate 1:1 ti receive 1.0mcg/kg of dexmedetomidine or same volume of nirmal saline. The solution is prepaired as a mixt

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients classified as American Society of Anesthesiologists physical status 1 or 2 who are scheduled undergoing elective closed reduction for nasal bone fracture

Exclusion criteria

Exclusion criteria: known allergies fo dexmedetomidine, medication of beta blocking agent,medication of alpha blocking agent, renal disease, hepatic dysfunction, signs of preoerative upper respiratory tract infection, diagnosed obstructive sleep apnea, diagnosed neuropsycholodical disease

Design outcomes

Primary

Measure	Time frame
incidence and severity of emergence agitation	—

Secondary

Measure	Time frame
reduce analgesics requirements postoperatively	—

Countries

Korea, Republic of

Contacts

Public ContactSangEun Lee

Myongji Hospital

Outcome results